Apr 02 2009

Spreading The Computational Load To Monitor Heart Patients Remotely

Published by poster under Uncategorized

The possibility of remote monitoring for chronically ill patients will soon become a reality. Now, researchers in South Africa and Australia have devised a decentralized system to avoid medical data overload. They describe the peer-to-peer system in a forthcoming issue of the International Journal of Computer Applications in Technology.
People with a range Continue Reading »

Comments Off

Apr 01 2009

Valdoxan(R) Granted Marketing Authorisation For The Treatment Of Major Depressive Episodes In Europe

Published by poster under Uncategorized

The European Commission has granted marketing authorisation for Servier’s
Valdoxan(R) /Thymanax(R) (agomelatine), the first melatonergic antidepressant
for the treatment of adult patients with major depressive episodes.
devastating effects of depression," said Professor Goodwin from Warneford
Hospital, Oxford, United Kingdom. "Valdoxan is Continue Reading »

Comments Off

Mar 31 2009

Stress May Cause The Brain To Become Disconnected

Published by poster under Uncategorized

Does stress damage the brain? In the March 1st issue of Biological Psychiatry, published by Elsevier, a paper by Tibor Hajszan and colleagues provides an important new chapter to this question.
This issue emerged in the 1990’s as an important clinical question with the observation by J. Douglas Bremner and colleagues, then at the VA National Center for Posttraumatic Stress Disorder (PTSD), that hippocampal volume was reduced Continue Reading »

Comments Off

Mar 30 2009

Depression Treatment And Increased Physical Activity In African Americans May Reduce Heart Disease And Improve Quality Of Life

Published by poster under Uncategorized

Identifying and treating depression, including increasing physical activity, may improve quality of life and reduce cardiovascular disease and death in African Americans, according to reports presented at the American Heart Association’s 2009 Conference on Nutrition, Physical Activity and Metabolism.
In one study, researchers in the Jackson Heart Study (JHS) found high depressive symptoms were prevalent Continue Reading »

Comments Off

Mar 26 2009

UC Davis Bench-To-Bedside Research: Promising Treatment For Diabetes, Hypertension And Inflammatory Disorders

Published by poster under Uncategorized

A new drug developed at the University of California, Davis to treat diabetes, hypertension and inflammatory has entered Phase II of human clinical trials to evaluate its efficacy.
Buy accutane The compound, a soluble epoxide hydrolase enzyme (s-EH) inhibitor, is "a first-in-class drug which may treat a suite Continue Reading »

Comments Off

Mar 13 2009

Study Suggests Salt Might Be ‘Nature’s Antidepressant’

Published by poster under Uncategorized

UI psychologist Kim Johnson and colleagues found in their research that when rats are deficient in sodium chloride, common table salt, they shy away from activities they normally enjoy, like drinking a sugary substance or pressing a bar that stimulates a pleasant sensation in their brains.
"Things that normally would be pleasurable for rats didn’t elicit the same degree of relish, which Continue Reading »

Comments Off

Mar 11 2009

Roche Signs Agreement With Evotec To Develop Evt 101 For Treatment-Resistant Depression

Published by poster under Uncategorized

Roche (SWX: RO, ROG;OTCQX: RHHBY) and Evotec (FSE: EVT; NASDAQ:EVTC) announced today that they have entered into an agreement for Phase II clinical development of EVT 101 in patients with treatment-resistant depression. The potential value of this transaction exceeds USD 300 million.
Evotec will be responsible for conducting Phase II studies for EVT 101, a compound originally discovered by Roche and developed from discovery Continue Reading »

Comments Off

Mar 11 2009

PSA testing may be unnecessary for some older men

Published by poster under Uncategorized

Certain men age 75 to 80 are unlikely to benefit from routine prostate specific antigen (PSA) testing, according to a Johns Hopkins study published in the April 2009 issue of The Journal of Urology.
The researchers found that men in this age group with PSA levels less than 3 nanograms per milliliter are unlikely to die of or experience aggressive prostate cancer during their remaining life, suggesting that Continue Reading »

Comments Off

Mar 09 2009

Increased Suicide Risk On Young Men Leaving The UK Armed Forces

Published by poster under Uncategorized

A new study in this week??s PLoS Medicine, reports that the risk of suicide increases two to three time on young men 24 years old or less who leave the UK Armed Forces than those remaining in active service or those in the general population.
In the first two years after discharge, the risk seems to increase in the men with short length of service, and those of inferior rank. Just 14 percent Continue Reading »

Comments Off

Mar 08 2009

Overcoming Dental Anxiety

Published by poster under Uncategorized

Do you feel anxious before every dentist appointment? Do you find yourself feeling sick to your stomach or getting sweaty palms? Is getting your child into the dentist chair like pulling teeth?
Though dental anxiety is quite common, the Pennsylvania Dental Association (PDA) reminds the public that this fear can be easily managed, and is even preventable.
For children, Continue Reading »

Comments Off

Feb 18 2009

Peanut Product Recall Spurs Six In Ten Americans To Take Steps To Reduce Risk Of Sickness

Published by poster under Uncategorized

Many mistakenly believe recall involves national brands of peanut butter and are not aware of the range of products involved
A new national survey conducted by the Harvard Opinion Research Program at the Harvard School of Public Health finds that the vast majority (93%) of Americans have heard or read about the recent ongoing recall of peanut products. Among those who are Continue Reading »

Comments Off

Feb 15 2009

Ligand Announces Phase IIb Results With DARA

Published by poster under Uncategorized

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) (the "Company" or "Ligand") announced positive preliminary results from the Phase IIb study for PS433540, the first-in-class Dual Acting Receptor Agonist (DARA) that targets the angiotensin and endothelin receptors.
The 261-patient, randomized, double-blind, placebo- and active-controlled study evaluated Continue Reading »

Comments Off

Feb 14 2009

VIVUS Initiates Second Pivotal Phase 3 Trial Of Avanafil For Treatment Of Erectile Dysfunction

Published by poster under Uncategorized

VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced it has initiated a second pivotal Phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED). Avanafil is a next-generation, fast-acting, Continue Reading »

Comments Off

Feb 14 2009

Study Examines Depression Among Arab, Chaldean, African Immigrants In Detroit

Published by poster under Uncategorized

"Factors Associated With Self-Reported Depression in Arab-, Chaldean-, and African-Americans" (.pdf), Ethnicity & Disease: Researchers led by Hikmet Jamil of Wayne State University and colleagues surveyed 3,543 adults of Arab, Chaldean and African backgrounds living in Detroit, seeking to determine ethnicity-specific Continue Reading »

Comments Off

Feb 11 2009

Erectile dysfunction doubles the risk of heart disease

Published by poster under Uncategorized

Scientists in the United States say they have discovered a link between heart disease and erectile dysfunction - they say in some cases that risk is doubled.
The researchers at the Mayo Clinic in Minnesota say they have found that men who experience erectile dysfunction between the ages of 40 and 49 are twice as likely to develop heart disease than men without the problem.
According to a new study the highest Continue Reading »

Comments Off

Feb 09 2009

Risk Of Further Suicide Attempts Increased By Nightmares

Published by poster under Uncategorized

A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, concludes that people who have nightmares following a suicide attempt are five times more likely to attempt suicide again, compared with those who do not have nightmares.
The study included 165 patients aged 18-69 years, who were being treated at somatic and psychiatric departments following a suicide attempt Continue Reading »

Comments Off

Feb 07 2009

This Month’s Family Murder-Suicides Only “The Tip Of The Iceberg” Sociologist Says

Published by poster under Uncategorized

A family sociologist at the University at Buffalo says this month’s murder-suicides involving a family of four in Ohio and a family of five in California may be "just the tip of the iceberg."
Sampson Blair, Ph.D., associate professor of sociology at UB, says, "Family murder-suicide is still relatively uncommon, but I expect an increase Continue Reading »

Comments Off

Feb 05 2009

Regional Effects Of 9/11 Attacks On Driving

Published by poster under Uncategorized

The September 11 terrorist attacks had a profound impact on this country’s psyche. Eight years after the attacks, we are still learning how those terrible events affected us. A number of studies have shown that people who lived closest to the sites of the terrorist attacks experienced heightened levels of stress and anxiety in the months following the September Continue Reading »

Comments Off

Feb 03 2009

National Breast Cancer Coalition Fund Awards 20 Advocacy In Action Grants

Published by poster under Uncategorized

The National Breast Cancer Coalition Fund has awarded 20 Advocacy in Action grants totaling $100,000 to member organizations selected by a competitive application process to assist groups in forwarding advocacy locally.
"These grants offer our member organizations support as they work to advance our goal of eradicating breast cancer," said Fran Visco, president of NBCCF. "The public Continue Reading »

Comments Off

Feb 01 2009

Association Between Antibodies To Cockroach, Mouse Proteins And Asthma, Allergies Risk

Published by poster under Uncategorized

generic zithromax online buy A study released by researchers at the Columbia Center for Children’s Environmental Health (CCCEH) at Columbia University’s Mailman School of Public Health shows that developing antibodies to cockroach and mouse proteins is associated with a greater risk for wheeze, hay fever, and eczema in preschool urban children as young as three years of age. Continue Reading »

Comments Off

Jan 31 2009

Comprehensive Analysis Shows Sertraline And Escitalopram Are The Best Of 12 New-Generation Antidepressants

Published by poster under Uncategorized

A comprehensive meta-analysis of 12 new-generation antidepressants has shown sertraline and escitalopram have clear advantages in terms of efficacy and acceptability, while reboxetine was shown to be the significantly less efficacious than the Continue Reading »

Comments Off

Jan 31 2009

Join Us For The Premier Allergy/immunology Meeting In 2009

Published by poster under Uncategorized

The world’s leading researchers in allergic disease will meet in Washington, DC, March 13-17, 2009, for the American Academy of Allergy, Asthma & Immunology’s (AAAAI) 2009 Annual Meeting. The AAAAI Annual Meeting is the largest U.S. gathering of allergist/immunologists, allied health professionals and researchers from around the world.
Medical, Consumer and Government Reporters will want to attend for these highlights:
- AAAAI Continue Reading »

Comments Off

Jan 29 2009

Men Under Stress Find Their Thinking Disrupted

Published by poster under Uncategorized

A new neuroimaging study on stressed-out students suggests that male humans, like male rats, don’t do their most agile thinking under stress. The findings, published this month in the Proceedings of the National Academy of Sciences, show that 20 male M.D. candidates in the middle of preparing for their board exams had a harder time shifting their attention from one task to another than other healthy young men who were not under the gun.
Previous experiments had Continue Reading »

Comments Off

Jan 28 2009

Hypertension And Cholesterol Medications Present In Treated Water Released Into The St. Lawrence River

Published by poster under Uncategorized

A study conducted by Universit?© de Montr?©al researchers on downstream and upstream water from the Montreal wastewater treatment plant has revealed the presence of chemotherapy products and certain hypertension and cholesterol medications.
Bezafibrate (cholesterol reducing medication), enalapril (hypertension medication), methotrexate and cyclophosphamide (two Continue Reading »

Comments Off

Jan 27 2009

New Data Presented For SEROQUEL XRTM In Major Depressive Disorder And Generalised Anxiety Disorder

Published by poster under Uncategorized

Two studies presented today at the 8th International Forum on Mood and Anxiety Disorders (IFMAD) in Vienna demonstrated that once-daily SEROQUEL XRTM (quetiapine fumarate extended release tablets) provided significant symptom relief for elderly patients (>65 years of age) with major depressive disorder Continue Reading »

Comments Off

Next »